Close

Ratings by H.C. Wainwright (Swayampakula Ramakanth)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
2/20/2024 Elevation Oncology ELEV Maintain Buy
(N/A)
 
 
  Details
2/16/2024 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
2/12/2024 Evaxion Biotech EVAX New Coverage Buy
(N/A)
4.02
(3.83)
-4.73% Details
1/24/2024 Ocugen, Inc. OCGN Maintain Buy
(N/A)
 
 
  Details
1/23/2024 Ekso Bionics EKSO Maintain Buy
(N/A)
 
 
  Details
1/22/2024 electroCore Inc. ECOR Maintain Buy
(N/A)
 
 
  Details
1/9/2024 Absci Corp. ABSI Maintain Buy
(N/A)
 
 
  Details
1/8/2024 Harpoon Therapeutics HARP Downgrade Neutral
(Buy)
10.55
(22.96)
117.63% Details
1/3/2024 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
12/8/2023 Quantum-SI Inc. QSI New Coverage Buy
(N/A)
1.55
(1.56)
0.65% Details
12/8/2023 Celcuity Inc CELC New Coverage Buy
(N/A)
14.83
(15.00)
1.15% Details
11/30/2023 Pyxis Oncology Inc. PYXS New Coverage Buy
(N/A)
1.56
(4.74)
203.85% Details
11/2/2023 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
10/4/2023 ALX Oncology ALXO Maintain Buy
(N/A)
 
 
  Details
9/29/2023 Elevation Oncology ELEV New Coverage Buy
(N/A)
0.68
(2.70)
297.06% Details
9/21/2023 MediWound Ltd MDWD Maintain Buy
(N/A)
 
 
  Details
9/21/2023 Vericel Corporation VCEL Maintain Buy
(N/A)
 
 
  Details
8/16/2023 Delcath Systems DCTH Maintain Buy
(N/A)
 
 
  Details
8/15/2023 Leap Therapeutics LPTX Maintain Buy
(N/A)
 
 
  Details
8/11/2023 HOOKIPA Pharma Inc. HOOK Maintain Buy
(N/A)
 
 
  Details
8/11/2023 ALX Oncology ALXO Maintain Buy
(N/A)
 
 
  Details
8/3/2023 Vericel Corporation VCEL Maintain Buy
(N/A)
 
 
  Details
8/3/2023 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
8/2/2023 MiMedx Group MDXG Maintain Buy
(N/A)
 
 
  Details
6/21/2023 MiMedx Group MDXG Maintain Buy
(N/A)
 
 
  Details
6/20/2023 Surface Oncology SURF Downgrade Neutral
(Buy)
0.79
(1.07)
35.44% Details
6/6/2023 Affimed Therapeutics AFMD Maintain Buy
(N/A)
 
 
  Details
5/9/2023 Codexis, Inc. CDXS Downgrade Neutral
(Buy)
3.41
(2.87)
-15.84% Details
5/4/2023 electroCore Inc. ECOR Maintain Buy
(N/A)
 
 
  Details
4/18/2023 electroCore Inc. ECOR Maintain Buy
(N/A)
 
 
  Details
4/13/2023 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
3/30/2023 Collplant Holdings Inc. CLGN Maintain Buy
(N/A)
 
 
  Details
3/28/2023 Delcath Systems DCTH Maintain Buy
(N/A)
 
 
  Details
3/22/2023 X4 Pharmaceuticals XFOR Maintain Buy
(N/A)
 
 
  Details
3/10/2023 electroCore Inc. ECOR Maintain Buy
(N/A)
 
 
  Details
3/6/2023 Asensus Surgical inc. ASXC Maintain Buy
(N/A)
 
 
  Details
3/1/2023 Ocugen, Inc. OCGN Maintain Buy
(N/A)
 
 
  Details
2/27/2023 Codexis, Inc. CDXS Maintain Buy
(N/A)
 
 
  Details
2/24/2023 Personalis PSNL Maintain Buy
(N/A)
 
 
  Details
2/15/2023 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
1/18/2023 Leap Therapeutics LPTX Maintain Buy
(N/A)
 
 
  Details
1/4/2023 MediWound Ltd MDWD Maintain Buy
(N/A)
 
 
  Details
1/4/2023 Vericel Corporation VCEL Maintain Buy
(N/A)
 
 
  Details
12/12/2022 Affimed Therapeutics AFMD New Coverage Buy
(N/A)
2.04
(0.53)
-74.02% Details
12/9/2022 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
11/30/2022 X4 Pharmaceuticals XFOR Maintain Buy
(N/A)
 
 
  Details
11/18/2022 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
11/16/2022 MediWound Ltd MDWD Maintain Buy
(N/A)
 
 
  Details
11/10/2022 Vericel Corporation VCEL Maintain Buy
(N/A)
 
 
  Details
11/9/2022 ALX Oncology ALXO Maintain Buy
(N/A)
 
 
  Details
11/7/2022 Verastem VSTM Maintain Buy
(N/A)
 
 
  Details
11/7/2022 Codexis, Inc. CDXS Maintain Buy
(N/A)
 
 
  Details
11/3/2022 Surface Oncology SURF Maintain Buy
(N/A)
 
 
  Details
11/3/2022 Personalis PSNL Maintain Buy
(N/A)
 
 
  Details
10/18/2022 AVEO Pharmaceuticals AVEO Downgrade Neutral
(Buy)
10.48
(15.00)
43.13% Details
8/30/2022 IN8bio Inc. INAB New Coverage Buy
(N/A)
1.98
(1.01)
-48.99% Details
8/29/2022 Calithera Biosciences CALA Upgrade Buy
(Neutral)
3.27
(0.37)
-88.69% Details
8/16/2022 Diffusion Pharma DFFN Upgrade Buy
(Neutral)
7.00
(4.40)
-37.14% Details
8/9/2022 Precigen Inc. PGEN Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Surface Oncology SURF Maintain Buy
(N/A)
 
 
  Details
8/8/2022 Codexis, Inc. CDXS Maintain Buy
(N/A)
 
 
  Details
7/20/2022 Vascular Biogenics Ltd VBLT Downgrade Neutral
(Buy)
2.05
(0.16)
-92.2% Details
6/22/2022 Celularity CELU New Coverage Buy
(N/A)
3.78
(0.43)
-88.62% Details
5/13/2022 X4 Pharmaceuticals XFOR Maintain Buy
(N/A)
 
 
  Details
5/13/2022 Pulse Biosciences PLSE Downgrade Neutral
(Buy)
1.48
(9.45)
538.51% Details
3/1/2022 ALX Oncology ALXO Maintain Buy
(N/A)
 
 
  Details
2/25/2022 Personalis PSNL Maintain Buy
(N/A)
 
 
  Details
2/17/2022 HOOKIPA Pharma Inc. HOOK Maintain Buy
(N/A)
 
 
  Details
2/10/2022 Pulse Biosciences PLSE Maintain Buy
(N/A)
 
 
  Details
12/17/2021 Vor Biopharma, Inc. VOR New Coverage Buy
(N/A)
12.13
(1.98)
-83.68% Details
12/13/2021 iTeos Therapeutics ITOS Maintain Buy
(N/A)
 
 
  Details
12/10/2021 Delcath Systems DCTH New Coverage Buy
(N/A)
8.02
(4.28)
-46.63% Details
11/16/2021 Pulse Biosciences PLSE Maintain Buy
(N/A)
 
 
  Details
11/8/2021 Calithera Biosciences CALA Downgrade Neutral
(Buy)
0.86
(0.37)
-56.98% Details
10/18/2021 Codexis, Inc. CDXS Maintain Buy
(N/A)
 
 
  Details
8/23/2021 Trillium Therapeutics TRIL Downgrade Neutral
(Buy)
6.09
(18.44)
202.79% Details
8/16/2021 Sesen Bio, Inc SESN Downgrade Neutral
(Buy)
2.11
(0.63)
-70.14% Details
7/12/2021 AVEO Pharmaceuticals AVEO Maintain Buy
(N/A)
 
 
  Details
7/6/2021 Janux Therapeutics JANX New Coverage Buy
(N/A)
25.40
(14.61)
-42.48% Details
6/23/2021 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
6/17/2021 Kindred Biosciences KIN Downgrade Neutral
(Buy)
9.23
(9.25)
0.22% Details
5/5/2021 iTeos Therapeutics ITOS New Coverage Buy
(N/A)
23.03
(9.91)
-56.97% Details
4/1/2021 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
3/2/2021 Ocugen, Inc. OCGN Maintain Buy
(N/A)
 
 
  Details
3/1/2021 ZIOPHARM Oncology ZIOP Downgrade Neutral
(Buy)
5.33
(0.87)
-83.68% Details
2/17/2021 Sesen Bio, Inc SESN Maintain Buy
(N/A)
 
 
  Details
2/10/2021 ALX Oncology ALXO New Coverage Buy
(N/A)
82.18
(16.05)
-80.47% Details
2/4/2021 Ocugen, Inc. OCGN Upgrade Buy
(Neutral)
2.81
(1.00)
-64.41% Details
1/21/2021 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
1/12/2021 Vericel Corporation VCEL Maintain Buy
(N/A)
 
 
  Details
1/5/2021 Calithera Biosciences CALA Maintain Buy
(N/A)
 
 
  Details
12/18/2020 Surface Oncology SURF Maintain Buy
(N/A)
 
 
  Details
11/27/2020 Corcept Therapeutics CORT Maintain Buy
(N/A)
 
 
  Details
11/17/2020 Diffusion Pharma DFFN Downgrade Neutral
(Buy)
0.66
(4.40)
566.67% Details
9/10/2020 Trillium Therapeutics TRIL Upgrade Buy
(Neutral)
13.59
(18.44)
35.69% Details
8/27/2020 Personalis PSNL New Coverage Buy
(N/A)
21.88
(1.25)
-94.29% Details
7/16/2020 ReWalk Robotics Ltd. RWLK Maintain Buy
(N/A)
 
 
  Details
6/26/2020 Ekso Bionics EKSO Maintain Buy
(N/A)
 
 
  Details
6/24/2020 Precigen Inc. PGEN Maintain Buy
(N/A)
 
 
  Details
6/15/2020 Ekso Bionics EKSO Maintain Buy
(N/A)
 
 
  Details
6/1/2020 Ocugen, Inc. OCGN Downgrade Neutral
(Buy)
0.31
(1.00)
222.58% Details
6/1/2020 AVEO Pharmaceuticals AVEO Maintain Buy
(N/A)
 
 
  Details
5/28/2020 Mesoblast Limited MESO Maintain Buy
(N/A)
 
 
  Details
5/12/2020 Pulse Biosciences PLSE Upgrade Buy
(Neutral)
11.74
(9.45)
-19.51% Details
4/7/2020 Pluristem Therapeutics PSTI Maintain Buy
(N/A)
 
 
  Details
4/3/2020 Collplant Holdings Inc. CLGN Maintain Buy
(N/A)
 
 
  Details
4/1/2020 EDAP TMS S.A. EDAP Maintain Buy
(N/A)
 
 
  Details
3/10/2020 electroCore Inc. ECOR New Coverage Buy
(N/A)
0.65
(6.93)
966.15% Details
3/6/2020 Alphatec Holdings ATEC Maintain Buy
(N/A)
 
 
  Details
3/3/2020 Forty Seven Inc. FTSV Downgrade Neutral
(Buy)
93.91
(95.51)
1.7% Details
2/14/2020 Pulse Biosciences PLSE Downgrade Neutral
(Buy)
12.18
(9.45)
-22.41% Details
2/12/2020 IsoRay, Inc. ISR Maintain Buy
(N/A)
 
 
  Details
2/6/2020 Mesoblast Limited MESO Maintain Buy
(N/A)
 
 
  Details
1/7/2020 X4 Pharmaceuticals XFOR New Coverage Buy
(N/A)
10.39
(0.91)
-91.24% Details
12/20/2019 Ocugen, Inc. OCGN New Coverage Buy
(N/A)
0.36
(0.31)
-13.89% Details
12/10/2019 Forty Seven Inc. FTSV Maintain Buy
(N/A)
 
 
  Details
11/19/2019 Calithera Biosciences CALA New Coverage Buy
(N/A)
3.38
(0.37)
-89.05% Details
11/11/2019 Æterna Zentaris AEZS Maintain Buy
(N/A)
 
 
  Details
10/28/2019 Ekso Bionics EKSO New Coverage Buy
(N/A)
0.59
(1.92)
225.42% Details
10/9/2019 Vericel Corporation VCEL New Coverage Buy
(N/A)
13.82
(48.31)
249.57% Details
9/17/2019 Pluristem Therapeutics PSTI Maintain Buy
(N/A)
 
 
  Details
9/12/2019 Tocagen Inc. TOCA Downgrade Neutral
(Buy)
4.18
(1.26)
-69.86% Details
9/11/2019 AVEO Pharmaceuticals AVEO Upgrade Buy
(Neutral)
0.92
(15.00)
1530.43% Details
9/6/2019 Corcept Therapeutics CORT New Coverage Buy
(N/A)
12.59
(22.99)
82.61% Details
8/19/2019 Trillium Therapeutics TRIL Downgrade Neutral
(Buy)
0.28
(18.44)
6485.71% Details
8/5/2019 MediWound Ltd MDWD New Coverage Buy
(N/A)
2.59
(13.26)
411.97% Details
6/17/2019 ReWalk Robotics Ltd. RWLK Upgrade Buy
(Neutral)
5.46
(1.05)
-80.77% Details
6/11/2019 Sesen Bio, Inc SESN Upgrade Buy
(Neutral)
2.32
(0.63)
-72.84% Details
6/5/2019 Zomedica ZOM New Coverage Buy
(N/A)
0.29
(0.12)
-58.62% Details
5/2/2019 Cellectar Biosciences CLRB New Coverage Buy
(N/A)
2.24
(3.35)
49.55% Details
3/15/2019 ReWalk Robotics Ltd. RWLK New Coverage Neutral
(N/A)
0.23
(5.46)
2273.91% Details
3/14/2019 Verastem VSTM Maintain Buy
(N/A)
 
 
  Details
3/7/2019 Gritstone Oncology GRTS New Coverage Buy
(N/A)
12.03
(2.07)
-82.79% Details
2/25/2019 Pulse Biosciences PLSE New Coverage Buy
(N/A)
18.23
(12.18)
-33.19% Details
2/1/2019 AVEO Pharmaceuticals AVEO Downgrade Neutral
(Buy)
1.77
(0.92)
-48.02% Details
1/31/2019 Mesoblast Limited MESO New Coverage Buy
(N/A)
4.58
(2.06)
-55.02% Details
1/28/2019 IsoRay, Inc. ISR New Coverage Buy
(Neutral)
0.39
(0.38)
-2.56% Details
1/4/2019 Sesen Bio, Inc SESN Downgrade Neutral
(Buy)
1.47
(2.32)
57.82% Details
12/24/2018 Histogenics Corp. HSGX Downgrade Neutral
(Buy)
0.47
(0.16)
-65.96% Details
12/18/2018 Advaxis ADXS Downgrade Neutral
(Buy)
0.24
(0.85)
254.17% Details
12/18/2018 Collplant Holdings Inc. CLGN New Coverage Buy
(N/A)
4.10
(5.37)
30.98% Details
11/30/2018 Forty Seven Inc. FTSV New Coverage Buy
(N/A)
18.38
(95.51)
419.64% Details
10/15/2018 Vascular Biogenics Ltd VBLT Upgrade Buy
(Neutral)
1.43
(0.16)
-88.81% Details
8/17/2018 Sesen Bio, Inc SESN Maintain Buy
(N/A)
 
 
  Details
8/16/2018 AVEO Pharmaceuticals AVEO New Coverage Buy
(N/A)
2.32
(1.77)
-23.71% Details
8/13/2018 Kindred Biosciences KIN Maintain Buy
(N/A)
 
 
  Details